Article
Virological Outcomes and Dolutegravir Resistance Mutations in HIV-infected Patients: A Multicenter Retrospective Cohort Study in Mozambique
2024-12-25
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction</bold> The global HIV epidemic remains a public health challenge. Dolutegravir (DTG) has become a cornerstone of antiretroviral therapy (ART) regimens due to its efficacy and tolerability. However, the emergence of DTG resistance is a concern. This study aims to evaluate virological outcomes and the emergence of resistance mutations in patients treated with DTG in Moz...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 00f24c94-5e74-57a1-b8b1-31731630e1c0
- DOI
- 10.21203/rs.3.rs-5676736/v1
